MannKind Corp. MannKind Corp. is a biopharmaceutical company. It focuses on the discovery, development and, commercialization of therapeutic products for diseases, such as diabetes and cancer. The company was founded by Alfred E. Mann on February 14, 1991 and is headquartered in Westlake Village, CA.What is MannKind's Afrezza?
MannKind Corporation, a biopharmaceutical company, focuses on the development and commercialization of inhaled therapeutic products for endocrine and orphan lung diseases in the United States. It offers Afrezza, an inhaled insulin used to improve glycemic control in adults with diabetes.How much is a share of MannKind stock?
One share of MNKD stock can currently be purchased for approximately $5.03. How much money does MannKind make? MannKind (NASDAQ:MNKD) has a market capitalization of $1.32 billion and generates $75.44 million in revenue each year.What is the mission of MannKind?
Our mission is to give people control of their health and the freedom to live life. Our strategy is focused on developing innovative medicines for both endocrine and orphan lung diseases. At MannKind, our Values serve as the foundation of our culture.